$13.63
0.070.52%
Últ. Act.: Nov 2, 4:00 PM
Trevi Therapeutics (TRVI) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.11 | $-0.07 | $-0.10 | $-0.10 |
| Actual | $-0.11 | $-0.09 | $-0.06 | $-0.08 |
| Surprise | 0.00% | -28.6% | +40.0% | +20.0% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | — | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.13 | $-0.14 | $-0.19 | $-0.21 |
| Revenue | ||||
| Consensus | — | — | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q2 | Aug 6, 2026 | $-0.11 | $-0.11 | 0.00 % |
| Q1 | May 5, 2026 | $-0.09 | $-0.07 | -28.6 % |
| Q4 | Mar 17, 2026 | $-0.06 | $-0.10 | 40.0 % |
| Q3 | Nov 13, 2025 | $-0.08 | $-0.10 | 20.0 % |